Latuda (lurasidone) is a prescription drug that’s prescribed to treat schizophrenia and bipolar disorder. Latuda comes as a tablet that you take by mouth. Latuda is prescribed to adults, adolescents, ...

As with other drugs, Latuda (lurasidone) can cause side effects, such as restlessness, nausea, and weight gain. If side effects of Latuda become difficult to tolerate, talk with your doctor or ...

The medicine is manufactured in Japan and Italy. The drug Latuda, which is used to treat schizophrenia and bipolar disorder ...

MARLBOROUGH, Mass. -- Sunovion Pharmaceuticals Inc. (Sunovion) today announced that Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent indicated for the treatment of adult ...

Mark Iwicki’s top priority is driving the success of Latuda, an atypical antipsychotic for adults with schizophrenia. “It’s the most important product and business we have for the next couple of years ...

Latuda (lurasidone) is a prescription drug that’s used to treat schizophrenia and depressive episodes related to bipolar I disorder. The drug comes as an oral tablet. It’s usually taken once per day.

Please provide your email address to receive an email when new articles are posted on . Sunovion recently announced that the FDA approved a supplemental New Drug Application for Latuda for the ...

Latuda's (lurasidone HCI; Sunovion) expanded indication has been approved for pediatric patients aged 10 to 17 years who have major depressive episodes associated with bipolar I disorder. The Food and ...

Sunovion's launch web site for its new schizophrenia drug Latuda uses an image of a man literally cracking up into pieces as his mother looks on adoringly. The bizarre image shows a smiling ...

Sunovion Pharmaceuticals Inc., a Marlborough based drug company now owned by Dainippon Sumitomo Pharma Co. Ltd. of Japan, said that it has received regulatory approval to market its Latuda drug for ...

Dainippon Sumitomo Pharma announced results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of Latuda (lurasidone; Sunovion) as adjunctive therapy and monotherapy, ...

Sunovion Pharmaceuticals' new antipsychotic drug has hit drugstores, aiming to capture a share of the already crowded market. It's a branded drug in a class that now includes one leading ...